Back to Hudson Bay Capital Management LP Hudson Bay Capital Management LP

ABTABT
Showing 7 of 10 quarters

Position history for Hudson Bay Capital Management LPHudson Bay Capital Management LP's holdings in ABBOTT LABORATORIES

Yes. Hudson Bay Capital holds 1,600,000 shares of ABT (Abbott Laboratories), worth $145.2M, as of its Q2 2026 13F filing. It increased the position from 75,000 shares in Q1 2026. Hudson Bay Capital has held ABT since Q1 2025, across 6 quarterly 13F filings. ABT is 0.4% of Hudson Bay Capital's reported 13F portfolio.

Current Value

$145.2M

Current Shares

1.6M

Total Value Change

+$145.2M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+2033.3%
$145.2M0.4%$89.55
58
2026-Q1
Increased
75,000
+400.0%
$7.7M0.0%$100.69
44
2025-Q4
Increased
15,000
+183.8%
$1.9M0.0%$122.25
42
2025-Q3
Decreased
5,285
-50.7%
$707,8730.0%$130.11
0
2025-Q2
Increased
10,725
+203.6%
$1.5M0.0%$131.53
41
2025-Q1
New
3,533
-
$468,6520.0%$127.69
33
2024-Q3
Exited
0
-100.0%
$00.0%$108.66
0

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used